Journal Logo

CAR T-Cell Collection

  • Updated:   7/6/2022
  • Contains:  22 items
Following the launch of the EHA Topics-In-Focus Immunotherapy, HemaSphere is publishing articles included in a special collection titled “CAR T-Cells: Hype and Hope”. This special collection focuses on the latest developments in the field of CAR T-cell therapy.

CAR T-cell Infusion Following Checkpoint Inhibition Can Induce Remission in Chemorefractory Post-transplant Lymphoproliferative Disorder of the CNS

Rösler, Wiebke; Bink, Andrea; Bissig, Marina; More

HemaSphere. 6(7):e733, July 2022.

The EHA Research Roadmap: Immune-based Therapies for Hematological Malignancies

Einsele, Hermann; Briones, Javier; Ciceri, Fabio; More

HemaSphere. 5(10):e642, October 2021.

CD38-specific Chimeric Antigen Receptor Expressing Natural Killer KHYG-1 Cells: A Proof of Concept for an “Off the Shelf” Therapy for Multiple Myeloma

Stikvoort, Arwen; van der Schans, Jort; Sarkar, Subhashis; More

HemaSphere. 5(7):e596, July 2021.

Bone Marrow Mesenchymal Stromal Cell-mediated Resistance in Multiple Myeloma Against NK Cells can be Overcome by Introduction of CD38-CAR or TRAIL-variant

Holthof, Lisa C.; Stikvoort, Arwen; van der Horst, Hilma J.; More

HemaSphere. 5(5):e561, May 2021.

Clinicopathologic Findings in Fatal Neurotoxicity After Adoptive Immunotherapy With CD19-Directed CAR T-Cells

Karschnia, Philipp; Strübing, Felix; Teske, Nico; More

HemaSphere. 5(3):e533, March 2021.